Potential Pharmacogenomics (PGx),Human Leukocyte Antigen (HLA) Antiviral to Cephalosporin Crossover Reaction

Abstract

Patient is an HLA-B*57:01 positive, 43-year-old male with a history of diabetes type II and admission 10 weeks ago at another institution for pubic symphysis osteomyelitis and associated pseudomonas. Cefepime IV was started and the patient presented with fevers, aches, agranulocytosis, thrombocytopenia and rash as a suspected side effect of cefepime after 3 weeks of treatment. Cefepime was replaced with piperacillin-tazobactam and symptoms resolved. Question to be resolved is whether an HLA-B*57:01 positive, abacavir sensitive patient could have an agranulocytosis cross reaction to cefepime.

Keywords

pharmacogenomics PGx HLA cefepime DRESS Stevens-Johnson syndrome abacavir

Get full access to this article

View all access options for this article.

References

Thompson

McLean-Tooke

Lucas

. Cross with caution: antibiotic cross-reactivity and Co-Reactivity patterns in severe cutaneous adverse reactions. Front Immunol. 2021;12:601954. doi:10.3389/fimmu.2021.601954. PMID: 33717082; PMCID: PMC7947317.

Adair

Meng

Naisbitt

. Drug hapten-specific T-cell activation: current status and unanswered questions. Proteomics. 2021;21(17-18):e2000267. doi:10.1002/pmic.202000267. Epub 2021 Jul 5. PMID: 33651918.

Whirl-Carrillo

Huddart

Gong

, et al. An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Therapeut. 2021;110(3):563-572.

Chenchula

Atal

Uppugunduri

CRS

. A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care. Pharmacogenomics J. 2024;24:9. doi:10.1038/s41397-024-00326-1.

Mallal

Phillips

Carosi

, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358(6):568-579. doi:10.1056/NEJMoa0706135. PMID: 18256392.

Abacavir package insert . Aurobindo pharma limited. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/077844PI.pdf. Accessed September 5, 2025.

Cefepime package insert . Apotex corporation. Available at: https://www.apotex.com/products/us/downloads/pre/cefe_inj_ins.pdf. Accessed September 5, 2025.

Wadelius

Eriksson

Kreutz

, et al. EuDAC. sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus. Clin Pharmacol Ther. 2018;103(5):843-853. doi:10.1002/cpt.805. Epub 2017 Sep 28. PMID: 28762467; PMCID: PMC5947520.

Liu

Wang

Liu

Xiao

. Literature review of the clinical features of sulfasalazine-induced drug reaction. With eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS). Front Pharmacol. 2024;15:1488483. doi:10.3389/fphar.2024.1488483.

10.

Cárdenas-Roldán

Rojas-Villarraga

Anaya

. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med. 2013;11:73. doi:10.1186/1741-7015-11-73. PMID: 23497011; PMCID: PMC3655934.

11.

Speicher

Crosby

Schuh

. Pharmacogenomics testing confirmation of carbamazepine induced DRESS reaction of an HLA-A*31:01 positive, polypharmacy patient. Inov Pharm. 2021;12(4):20. doi:10.24926/iip.v12i4.4341.

12.

Schuh

Garcia

. Somatization in polypharmacy: hiding in plain sight. Inov Pharm. 2024;15(2):5.

13.

Schuh

Crosby

. Chronic anticholinergic toxicity discovered in a pharmacogenomics, polypharmacy patient. Sr Care Pharm. 2021;36(6):304-310. doi:10.4140/TCP.n.2021.304. PMID: 34016227.